CLINICAL_TRIALS
trial_result
· 2025-04-02
Clinical Trial Update: Neo-DIANA: Neoadjuvant Treatment for EGFR Mutated Patients [Phase 2]
Summary
A Phase 2 neoadjuvant trial for EGFR-mutated non-small cell lung cancer (Neo-DIANA) was terminated, with results posted in 2025.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Fundación GECP | Conditions: Non Small Cell Lung Cancer, EGFR Gene Mutation | Phase 2 | Status: TERMINATED | Results posted: 2025-04-02